6XJ-51515-87363
3 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 923 / CA
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
EGE-79736-83641
Child or adolescent in my care · Female · 2022-06-27
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-02-01
Registered in v-safe
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2022-02-19
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-10-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release